Mohammed Najeeb Al-Hallak

6PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 22, 2024
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.

Elisabeth Heath, Gregory Dyson, Jennifer R Ribeiro

|Jan 08, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis.

Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan

|Sep 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel

|Apr 03, 2020
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth.

Husain Yar Khan, Gabriel B Mpilla, Rachel Sexton

|Dec 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma.

Asfar S Azmi, Husain Yar Khan, Irfana Muqbil

|Jul 15, 2016
Risk and Surveillance of Cancers in Primary Biliary Tract Disease.

Valery Hrad, Yoftahe Abebe, Syed Haris Ali

Pageof 1

Frequent Collaborators

4 joint publications

Asfar S Azmi

3 joint publications

Husain Yar Khan

2 joint publications

Eliza W Beal

2 joint publications

Sahar F Bannoura